» Articles » PMID: 37699202

Neutral Sphingomyelinase Blockade Enhances Hematopoietic Stem Cell Fitness Through an Integrated Stress Response

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2023 Sep 12
PMID 37699202
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem and progenitor cell (HSPC) transplantation serves as a curative therapy for many benign and malignant hematopoietic disorders and as a platform for gene therapy. However, growing needs for ex vivo manipulation of HSPC-graft products are limited by barriers in maintaining critical self-renewal and quiescence properties. The role of sphingolipid metabolism in safeguarding these essential cellular properties has been recently recognized, but not yet widely explored. Here, we demonstrate that pharmacologic and genetic inhibition of neutral sphingomyelinase 2 (nSMase-2) leads to sustained improvements in long-term competitive transplantation efficiency after ex vivo culture. Mechanistically, nSMase-2 blockade activates a canonical integrated stress response (ISR) and promotes metabolic quiescence in human and murine HSPCs. These adaptations result in part from disruption in sphingolipid metabolism that impairs the release of nSMase-2-dependent extracellular vesicles (EVs). The aggregate findings link EV trafficking and the ISR as a regulatory dyad guarding HSPC homeostasis and long-term fitness. Translationally, transient nSMase-2 inhibition enables ex vivo graft manipulation with enhanced HSPC potency.

Citing Articles

Emerging roles of the acid sphingomyelinase/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications.

Wang H, Wang Y, Zhang S, Bai L World J Cardiol. 2025; 17(2):102308.

PMID: 40061281 PMC: 11886385. DOI: 10.4330/wjc.v17.i2.102308.


Defining 'Intention' in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy.

Milrod C, Steuer R, Pelcovits A Blood Cancer J. 2025; 15(1):16.

PMID: 39922824 PMC: 11807103. DOI: 10.1038/s41408-025-01220-0.


CCR2 cooperativity promotes hematopoietic stem cell homing to the bone marrow.

Hurwitz S, Kobulsky D, Jung S, Chia J, Butler J, Kurre P Sci Adv. 2024; 10(38):eadq1476.

PMID: 39292787 PMC: 11409967. DOI: 10.1126/sciadv.adq1476.


Metabolism and HSC fate: what NADPH is made for.

Morganti C, Bonora M, Ito K Trends Cell Biol. 2024; .

PMID: 39054107 PMC: 11757803. DOI: 10.1016/j.tcb.2024.07.003.


A mitochondrial NADPH-cholesterol axis regulates extracellular vesicle biogenesis to support hematopoietic stem cell fate.

Bonora M, Morganti C, van Gastel N, Ito K, Calura E, Zanolla I Cell Stem Cell. 2024; 31(3):359-377.e10.

PMID: 38458178 PMC: 10957094. DOI: 10.1016/j.stem.2024.02.004.

References
1.
Goldberg L . Extracellular Vesicles and Hematopoietic Stem Cell Aging. Arterioscler Thromb Vasc Biol. 2021; 41(8):e399-e416. DOI: 10.1161/ATVBAHA.120.314643. View

2.
Ding C, Shrestha R, Zhu X, Geller A, Wu S, Woeste M . Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis. Nat Immunol. 2023; 24(2):239-254. PMC: 10636755. DOI: 10.1038/s41590-022-01388-8. View

3.
Wilkinson A, Ishida R, Nakauchi H, Yamazaki S . Long-term ex vivo expansion of mouse hematopoietic stem cells. Nat Protoc. 2020; 15(2):628-648. PMC: 7206416. DOI: 10.1038/s41596-019-0263-2. View

4.
Watts K, Adair J, Kiem H . Hematopoietic stem cell expansion and gene therapy. Cytotherapy. 2011; 13(10):1164-71. PMC: 3291512. DOI: 10.3109/14653249.2011.620748. View

5.
Kruta M, Sunshine M, Chua B, Fu Y, Chawla A, Dillingham C . Hsf1 promotes hematopoietic stem cell fitness and proteostasis in response to ex vivo culture stress and aging. Cell Stem Cell. 2021; 28(11):1950-1965.e6. PMC: 8571035. DOI: 10.1016/j.stem.2021.07.009. View